|
|
||||||||
1 Unitat de Bioquímica, Campus de Bellvitge, Universitat de Barcelona, 08907 Barcelona; and 2 Department of Medical Bioanalysis, Instituto de Investigaciones Biomédicas de Barcelona, Consejo Superior de Investigaciones Científicas, Institut d'Investigacions Biomediques August Pi i Sunyer, 08036 Barcelona, Spain
We evaluated the possibility that ischemic preconditioning could modify hepatic energy metabolism during ischemia. Accordingly, high-energy nucleotides and their degradation products, glycogen and glycolytic intermediates and regulatory metabolites, were compared between preconditioned and nonpreconditioned livers. Preconditioning preserved to a greater extent ATP, adenine nucleotide pool, and adenylate energy charge; the accumulation of adenine nucleosides and bases was much lower in preconditioned livers, thus reflecting slower adenine nucleotide degradation. These effects were associated with a decrease in glycogen depletion and reduced accumulation of hexose 6-phosphates and lactate. 6-Phosphofructo-2-kinase decreased in both groups, reducing the availability of fructose-2,6-bisphosphate. Preconditioning sustained metabolite concentration at higher levels although this was not correlated with an increased glycolytic rate, suggesting that adenine nucleotides and cAMP may play the main role in the modulation of glycolytic pathway. Preconditioning attenuated the rise in cAMP and limited the accumulation of hexose 6-phosphates and lactate, probably by reducing glycogen depletion. Our results suggest the induction of metabolic arrest and/or associated metabolic downregulation as energetic cost-saving mechanisms that could be induced by preconditioning.
adenosine 5'-triphosphate; glycogen; adenosine 3',5'-cyclic monophosphate; glucose; fructose
This article has been cited by other articles:
![]() |
B. Viollet, M. Foretz, B. Guigas, S. Horman, R. Dentin, L. Bertrand, L. Hue, and F. Andreelli Activation of AMP-activated protein kinase in the liver: a new strategy for the management of metabolic hepatic disorders J. Physiol., July 1, 2006; 574(1): 41 - 53. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. U. Niemann, R. Hirose, T. Liu, M. Behrends, J. L. Brown, D. F. Kominsky, J. P. Roberts, and N. Serkova Ischemic Preconditioning Improves Energy State and Transplantation Survival in Obese Zucker Rat Livers Anesth. Analg., December 1, 2005; 101(6): 1577 - 1583. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Chouker, A. Martignoni, R. Schauer, M. Dugas, H.-G. Rau, K.-W. Jauch, K. Peter, and M. Thiel Beneficial Effects of Ischemic Preconditioning in Patients Undergoing Hepatectomy: The Role of Neutrophils Arch Surg, February 1, 2005; 140(2): 129 - 136. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Chouker, T. Schachtner, R. Schauer, M. Dugas, F. Lohe, A. Martignoni, B. Pollwein, M. Niklas, H. G. Rau, K. W. Jauch, et al. Effects of Pringle manoeuvre and ischaemic preconditioning on haemodynamic stability in patients undergoing elective hepatectomy: a randomized trial Br. J. Anaesth., August 1, 2004; 93(2): 204 - 211. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Mieno, H. Horimoto, F. Watanabe, Y. Nakai, E. Furuya, and S. Sasaki Potent adenylate cyclase agonist forskolin restores myoprotective effects of ischemic preconditioning in rat hearts after myocardial infarction Ann. Thorac. Surg., October 1, 2002; 74(4): 1213 - 1218. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Peralta, J. C. Perales, R. Bartrons, C. Mitchell, H. Gilgenkrantz, C. Xaus, N. Prats, L. Fernandez, E. Gelpi, J. Panes, et al. The Combination of Ischemic Preconditioning and Liver Bcl-2 Overexpression Is a Suitable Strategy to Prevent Liver and Lung Damage after Hepatic Ischemia-Reperfusion Am. J. Pathol., June 1, 2002; 160(6): 2111 - 2122. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |